BridgeMD
New treatment option for Neonatal İntensive Care
Official title The Effect of PIOMI and Chronobiological Nutrition on Readiness for Feeding, Full Transition to Oral Feeding and Body Weight
ClinicalTrials.gov ID: NCT07306793
What this study is testing
- What it's testing
- This is a randomized controlled experimental study evaluating the effects of oral motor intervention and chronobiological approach to feeding model applied to preterm infants on feeding readiness, transition to total oral feeding and body weight.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 29 to 33. Healthy volunteers may be eligible.
You may be able to join if
- Preterm infants with a postnatal age of 29-33 weeks,
- Whose vital signs and clinical condition have been stable for at least 24 hours,
- Whose APGAR score at 1 and 5 minutes (Activity-Pulse-Grimace-Appearance-Respiration) is 4 or higher.
You likely can't join if
- Infants with major congenital anomalies (such as congenital heart disease, cleft palate, cleft lip) or birth trauma,
- Infants with RDS,
- Infants diagnosed with asphyxia,
- Infants with intraventricular hemorrhage,
- Infants with Neonatal Withdrawal Syndrome,
- Infants with Fetal Alcohol Syndrome,
See the full eligibility criteria
- Preterm infants with a postnatal age of 29-33 weeks,
- Whose vital signs and clinical condition have been stable for at least 24 hours,
- Whose APGAR score at 1 and 5 minutes (Activity-Pulse-Grimace-Appearance-Respiration) is 4 or higher.
- Infants with major congenital anomalies (such as congenital heart disease, cleft palate, cleft lip) or birth trauma,
- Infants with RDS,
- Infants diagnosed with asphyxia,
- Infants with intraventricular hemorrhage,
- Infants with Neonatal Withdrawal Syndrome,
- Infants with Fetal Alcohol Syndrome,
- Infants included in the study group who develop any complications or whose stable condition deteriorates during the follow-up period,
- Infants with feeding intolerance or who are interrupted from feeding for more than 48 hours,
- Infants who develop sepsis,
- Infants who develop necrotizing enterocolitis,
- Infants receiving mechanical ventilation support,
- Infants who receive narcotic analgesia or sedation,
The study team makes the final eligibility decision.
Where it's taking place
- Aydin, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 29 weeks to 33 weeks. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Aydin, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.